Recently, we applied gene expression microarrays and identified fibulin-1 (FBLN1) as a molecular marker of cardiovascular disease in non-atherosclerotic tissue from patients with type 2 diabetes [18]. This evidence concerns the gene FBLN1 and cardiovascular disorder.